Aster DM Healthcare Ltd

₹ 233 2.49%
07 Dec - close price
About

Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]

Key Points

Network
The Co. is an emerging player in India through its network of 27 hospitals, 120 clinics, 371 pharmacies, 14 labs & 100 patient experience centres as on March 31, 2022. [1]

  • Market Cap 11,634 Cr.
  • Current Price 233
  • High / Low 276 / 158
  • Stock P/E 23.8
  • Book Value 83.0
  • Dividend Yield 0.00 %
  • ROCE 11.6 %
  • ROE 16.0 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 2.81 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 11.6% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 12.2% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
2,087 2,322 2,280 1,761 2,243 2,228 2,391 2,372 2,504 2,650 2,728 2,662 2,816
1,842 1,937 1,876 1,618 1,972 1,900 2,070 2,091 2,162 2,252 2,267 2,370 2,498
Operating Profit 245 385 404 143 271 328 321 281 343 397 460 292 319
OPM % 12% 17% 18% 8% 12% 15% 13% 12% 14% 15% 17% 11% 11%
4 -14 25 8 9 7 30 9 10 12 22 37 18
Interest 88 71 112 80 75 62 77 66 61 67 62 69 77
Depreciation 149 140 171 155 153 157 153 153 156 161 170 175 189
Profit before tax 12 160 146 -85 53 115 122 70 135 181 250 85 71
Tax % 42% 5% -0% -5% 20% 7% 4% 15% 6% 7% 2% 6% 23%
Net Profit 7 151 146 -89 42 107 117 60 128 168 246 80 54
EPS in Rs 0.06 2.75 2.62 -1.66 0.66 1.85 2.11 0.89 2.14 2.97 4.53 1.37 0.93
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
1,922 2,871 3,876 5,250 5,931 6,721 7,963 8,652 8,608 10,253 10,856
1,660 2,421 3,370 4,805 5,582 6,089 6,886 7,187 7,506 8,720 9,388
Operating Profit 261 451 506 445 349 632 1,077 1,465 1,103 1,533 1,468
OPM % 14% 16% 13% 8% 6% 9% 14% 17% 13% 15% 14%
11 19 23 25 453 177 -155 -158 53 51 90
Interest 45 48 79 189 371 204 205 391 334 307 275
Depreciation 76 111 144 243 322 298 306 586 618 641 696
Profit before tax 151 310 306 38 108 308 410 330 205 637 587
Tax % 4% 9% 11% 78% 10% 8% 10% 5% 13% 6%
Net Profit 149 284 272 8 98 282 367 315 178 601 548
EPS in Rs 7.26 4.69 7.00 0.20 2.52 5.32 6.59 5.54 2.96 10.53 9.80
Dividend Payout % 0% 35% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 9%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 30%
3 Years: 2%
TTM: 40%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 15%
1 Year: 21%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 12%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
125 375 389 403 403 505 505 497 497 497 497
Reserves 654 536 1,096 17 1,034 1,952 2,334 2,401 2,501 3,082 3,649
505 886 1,091 3,321 2,758 2,352 2,788 5,605 4,804 4,907 5,262
856 1,097 1,834 2,003 2,609 2,670 3,300 3,903 3,818 4,035 4,237
Total Liabilities 2,140 2,894 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 13,646
872 1,087 2,237 2,507 3,520 3,738 4,289 7,124 6,749 7,009 7,924
CWIP 185 357 197 358 290 402 550 736 934 998 712
Investments 6 7 3 39 32 38 22 34 63 45 44
1,077 1,442 1,972 2,839 2,962 3,302 4,067 4,511 3,874 4,470 4,967
Total Assets 2,140 2,894 4,409 5,743 6,804 7,479 8,928 12,405 11,620 12,521 13,646

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
236 203 361 537 601 1,223 1,569 1,313
-439 -775 -1,136 -522 -702 -658 -333 -563
203 578 654 46 134 -675 -1,116 -685
Net Cash Flow -1 5 -122 61 33 -110 120 65

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 95 86 83 93 79 84 93 100 86 72
Inventory Days 84 71 93 92 102 111 110 138 122 129
Days Payable 213 176 178 187 151 150 153 303 290 267
Cash Conversion Cycle -34 -18 -2 -1 30 45 50 -65 -83 -66
Working Capital Days 82 61 69 68 57 59 57 40 38 40
ROCE % 23% 18% 7% 2% 8% 15% 13% 7% 12%

Shareholding Pattern

Numbers in percentages

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
37.80 37.87 37.88 37.88 37.88 37.88 37.88 37.88 37.88 37.88 37.88 37.88
13.07 10.81 10.49 10.54 10.92 10.57 8.69 10.80 10.95 11.03 11.44 11.77
4.95 6.51 8.49 8.55 8.50 8.72 9.64 8.48 8.45 8.64 9.66 8.99
43.60 44.23 42.59 42.48 42.19 42.33 43.30 42.36 42.24 41.99 40.57 40.91
0.57 0.58 0.55 0.55 0.50 0.50 0.49 0.48 0.47 0.46 0.45 0.45

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents